Characteristics of the three sets of explicit criteria and their performance in detecting potentially inappropriate medications (PIMs) in Taiwanese study patients in 2009
| Beers criteria | PIM-Taiwan criteria | PRISCUS criteria | |
|---|---|---|---|
| Year of criteria | 2012 | 2012 | 2010 |
| Country | USA | Taiwan | German |
| Statements* | 34 | 24 | 15 |
| Number of medications† | 137 | 84 | 83 |
| Availability of PIMs listed in each set of criteria in Taiwan | 105 (76.64%) | 84 (100%) | 69 (84.15%) |
| Number of patients with any PIMs | 1 004 234 (86.22%) | 853 915 (73.32%) | 778 825 (66.87%) |
*Statements are those for potentially inappropriate medications (PIMs) without considering drug–disease or drug–syndrome interactions.
†Medications are considered as potentially inappropriate without considering drug–disease or drug–syndrome interactions.